Impact of Silver and Iron Nanoparticle Exposure on Cholesterol Uptake by Macrophages

Journal of Nanomaterials

Volumn 2015, Issue , 2015, Pages

  Shannahan, Jonathan H ^a   Sowrirajan, Hari ^b   Persaud, Indushekhar ^a   Podila, Ramakrishna ^c   Brown, Jared M ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Cherry Creek School District   (United States)

^c CLEMSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR SYSTEM; CHOLESTEROL; CYTOTOXICITY; IRON; IRON COMPOUNDS; MEDICAL APPLICATIONS; NANOPARTICLES;

BIOLOGICAL INTERACTIONS; BIOMEDICAL APPLICATIONS; CELLULAR FUNCTION; CHOLESTEROL UPTAKES; IRON NANOPARTICLES; NANOPARTICLE (NPS); SCAVENGER RECEPTOR; VASCULAR SYSTEM;

MACROPHAGES;

EID: 84946944145     PISSN: 16874110     EISSN: 16874129     Source Type: Journal    
DOI: 10.1155/2015/127235     Document Type: Article

References (36)

1. J.-J. Lin, W.-C. Lin, R.-X. Dong, and S.-H. Hsu, "The cellular responses and antibacterial activities of silver nanoparticles stabilized by different polymers," Nanotechnology, vol. 23, no. 6, Article ID 065102, 2012.
2. F. Martńez-Gutiérrez, J. M. Guajardo-Pacheco, M. E. Noriega-Trevino et al. , "Antimicrobial activity, cytotoxicity and inflammatory response of novel plastics embedded with silver nanoparticles," Future Microbiology, vol. 8, no. 3, pp. 403-411, 2013.
3. M. Ahamed, M. S. AlSalhi, and M. K. J. Siddiqui, "Silver nanoparticle applications and human health," Clinica Chimica Acta, vol. 411, no. 23-24, pp. 1841-1848, 2010.
4. T. M. Tolaymat,A. M. ElBadawy, A. Genaidy, K. G. Scheckel,T. P. Luxton, and M. Suidan, "An evidence-based environmental perspective of manufactured silver nanoparticle in syntheses and applications: a systematic review and critical appraisal of peer-reviewed scientific papers," Science of the Total Environment, vol. 408, no. 5, pp. 999-1006, 2010.
5. H. Amiri, L. Bordonali, A. Lascialfari et al. , "Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles," Nanoscale, vol. 5, no. 18, pp. 8656-8665, 2013.
6. H.-Y. Huang, S.-H. Hu, S.-Y. Hung et al. , "SPIO nanoparticlestabilized PAA-F127 thermosensitive nanobubbles with MR/US dual-modality imaging and HIFU-triggered drug release for magnetically guided in vivo tumor therapy," Journal of Controlled Release, vol. 172, no. 1, pp. 118-127, 2013.
7. A. K. Gupta and M. Gupta, "Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications," Biomaterials, vol. 26, no. 18, pp. 3995-4021, 2005.
8. R. Foldbjerg, D. A. Dang, and H. Autrup, "Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549," Archives of Toxicology, vol. 85, no. 7, pp. 743-750, 2011.
9. S. Grosse,L. Evje, andT. Syversen, "Silvernanoparticle-induced cytotoxicity in rat brain endothelial cell culture," Toxicology in Vitro, vol. 27, no. 1, pp. 305-313, 2013.
10. S. Lanone, F. Rogerieux, J. Geys et al. , "Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines," Particle and Fibre Toxicology, vol. 6, article 14, 2009.
11. S. Park, Y. K. Lee, M. Jung et al. , "Cellular toxicity of various inhalable metal nanoparticles on human alveolar epithelial cells," Inhalation Toxicology, vol. 19, supplement 1, pp. 59-65, 2007.
12. J. H. Shannahan, R. Podila, A. A. Aldossari et al. , "Formation of a protein corona on silver nanoparticles mediates cellular toxicity via scavenger receptors," Toxicological Sciences, vol. 143, no. 1, pp. 136-146, 2014.
13. Z. Magdolenova, M. Drlickova, K. Henjum et al. , "Coatingdependent induction of cytotoxicity and genotoxicity of iron oxide nanoparticles," Nanotoxicology, vol. 9, no. 1, pp. 44-56, 2015.
14. M. Watanabe,M. Yoneda, A. Morohashi et al. , "Effects of Fe3O4 magnetic nanoparticles on A549 cells," International Journal of Molecular Sciences, vol. 14, no. 8, pp. 15546-15560, 2013.
15. M. S. Hazari, J. Griggs, D. W. Winsett et al. , "A single exposure to acrolein desensitizes baroreflex responsiveness and increases cardiac arrhythmias in normotensive and hypertensive rats," Cardiovascular Toxicology, vol. 14, no. 1, pp. 52-63, 2014.
16. L. Sun, C. Liu, X. Xu et al. , "Ambient fine particulate matter and ozone exposures induce inflammation in epicardial and perirenal adipose tissues in rats fed a high fructose diet," Particle and Fibre Toxicology, vol. 10, no. 1, article 43, 2013.
17. U. P. Kodavanti, M. C. Schladweiler, A. D. Ledbetter et al. , "The spontaneously hypertensive rat as amodel of human cardiovascular disease: evidence of exacerbated cardiopulmonary injury and oxidative stress from inhaled emission particulate matter," Toxicology and Applied Pharmacology, vol. 164, no. 3, pp. 250-263, 2000.
18. J. H. Shannahan,W. Bai, and J. M. Brown, "Implications of scavenger receptors in the safe development of nanotherapeutics," Receptors & Clinical Investigation, vol. 2, no. 3, article e811, 2015.
19. H. Wang, L. Wu, and B. M. Reinhard, "Scavenger receptor mediated endocytosis of silver nanoparticles into J774A. 1 macrophages is heterogeneous," ACS Nano, vol. 6, no. 8, pp. 7122-7132, 2012.
20. A. Rigotti, H. E. Miettinen, and M. Krieger, "The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues," Endocrine Reviews, vol. 24, no. 3, pp. 357-387, 2003.
21. J. Kzhyshkowska, C. Neyen, and S. Gordon, "Role of macrophage scavenger receptors in atherosclerosis," Immunobiology, vol. 217, no. 5, pp. 492-502, 2012.
22. A. A. Aldossari, J. H. Shannahan, R. Podila, and J. M. Brown, "Influence of physicochemical properties of silver nanoparticles on mast cell activation and degranulation," Toxicology in Vitro, vol. 29, no. 1, pp. 195-203, 2015.
23. A. Rigotti, B. L. Trigatti, M. Penman, H. Rayburn, J. Herz, and M. Krieger, "A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism," Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 23, pp. 12610-12615, 1997.
24. R. P. Singh and P. Ramarao, "Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles," Toxicology Letters, vol. 213, no. 2, pp. 249-259, 2012.
25. T. Xia, R. F. Hamilton Jr. , J. C. Bonner et al. , "Interlaboratory evaluation of in vitro cytotoxicity and inflammatory responses to engineered nanomaterials: the NIEHS Nano go consortium," Environmental Health Perspectives, vol. 121, no. 6, pp. 683-690, 2013.
26. N. A. Monteiro-Riviere, M. E. Samberg, S. J. Oldenburg, and J. E. Riviere, "Protein binding modulates the cellular uptake of silver nanoparticles into human cells: implications for in vitro to in vivo extrapolations?" Toxicology Letters, vol. 220, no. 3, pp. 286-293, 2013.
27. J. H. Shannahan, X. Lai, P. C. Ke, R. Podila, J. M. Brown, and F. A. Witzmann, "Silver nanoparticle protein corona composition in cell culturemedia," PLoSONE, vol. 8, no. 9,Article IDe74001, 2013.
28. C. D. Walkey and W. C. W. Chan, "Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment," Chemical Society Reviews, vol. 41, no. 7, pp. 2780-2799, 2012.
29. R. M. Zucker and K. M. Daniel, "Detection of TiO2 nanoparticles in cells by flow cytometry," Methods in Molecular Biology, vol. 906, pp. 497-509, 2012.
30. Y. Toduka, T. Toyooka, and Y. Ibuki, "Flow cytometric evaluation of nanoparticles using side-scattered light and reactive oxygen species-mediated fluorescence-correlation with genotoxicity," Environmental Science and Technology, vol. 46, no. 14, pp. 7629-7636, 2012.
31. D. S. Anderson, E. S. Patchin, R. M. Silva et al. , "Influence of particle size on persistence and clearance of aerosolized silver nanoparticles in the rat lung," Toxicological Sciences, vol. 144, no. 2, pp. 366-381, 2015.
32. G. Valacchi, C. Sticozzi, Y. Lim, and A. Pecorelli, "Scavenger receptor class B type I: a multifunctional receptor," Annals of the New York Academy of Sciences, vol. 1229, pp. E1-E7, 2011.
33. L. K. Petersen, A. W. York, D. R. Lewis et al. , "Amphiphilic nanoparticles repress macrophage atherogenesis: novel core/shell designs for scavenger receptor targeting and down-regulation," Molecular Pharmaceutics, vol. 11, no. 8, pp. 2815-2824, 2014.
34. Y. Suzuki, S. Tada-Oikawa, G. Ichihara et al. , "Zinc oxide nanoparticles induce migration and adhesion of monocytes to endothelial cells and accelerate foamcell formation," Toxicology and Applied Pharmacology, vol. 278, no. 1, pp. 16-25, 2014.
35. G. Schäfer, R. Guler, G. Murray, F. Brombacher, and G. D. Brown, "The role of scavenger receptor B1 in infection with Mycobacteriumtuberculosis in amurinemodel," PLoS ONE, vol. 4, no. 12, Article ID e8448, 2009.
36. V. Kodali, M. H. Littke, S. C. Tilton et al. , "Dysregulation of macrophage activation profiles by engineered nanoparticles," ACS Nano, vol. 7, no. 8, pp. 6997-7010, 2013.